Market Cap 4.08M
Revenue (ttm) 90,000.00
Net Income (ttm) -13.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15,511.11%
Debt to Equity Ratio 0.10
Volume 983,100
Avg Vol 34,381,637
Day's Range N/A - N/A
Shares Out 14.56M
Stochastic %K 15%
Beta 1.20
Analysts Sell
Price Target $5.25

Company Profile

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon produ...

Industry: Biotechnology
Sector: Healthcare
Phone: 352 448 7797
Fax: 352 480 4620
Address:
2117 SW Highway 484, Ocala, United States
Chessdoc
Chessdoc Jul. 3 at 9:00 PM
$AIM https://www.statnews.com/2026/06/30/marburg-virus-cases-ugandan-ebola-outbreak-zone/ Since Marburg is closely related to Ebola, Ampligen might have similar potential, but there are no published studies testing it directly against Marburg
0 · Reply
ultimatebastos
ultimatebastos Jul. 2 at 3:11 PM
$AIM what is wrong why are the moronic naked shorting thieves shorting so ineffective? And why do the still bash on this bord every day after they made the yahoo thief support board useless?
1 · Reply
Jasonbush
Jasonbush Jul. 2 at 3:03 PM
$AIM great drug terrible CEO
0 · Reply
jonjonson1234
jonjonson1234 Jul. 2 at 2:08 PM
$AIM For AIM insiders, the company has been a nice source of extra retirement income. All they have do is put in a few hours here and there going through the motions of running a hokey pantomime of a biotech, and then they can go back to riding horses, self-publishing books, playing golf, taking naps, etc. (For William Mitchell, at 91, it is probably mostly naps at this point). Thomas K. Equels, M.S., J.D. 73 Chief Executive Officer, President and Director Nancy Bryan, MBA 68 Director William M. Mitchell, M.D., Ph.D. 91 Chair of the Board and Director Ted D. Kellner 79 Director David Chemerow, MBA 74 Director Peter W. Rodino III, Esq. 74 Chief Operating Officer, General Counsel and Secretary Robert Dickey IV, MBA 70 Chief Financial Officer
1 · Reply
whatnow_32
whatnow_32 Jul. 2 at 1:42 PM
$AIM I voted NO for every option. This company would be better on the pink sheets. AND wtf is Tom doing every day to get Ampligen as a treatment for ebola? AND wtf are Kellner and Chemerow doing now that they have their board seats?
1 · Reply
ultimatebastos
ultimatebastos Jul. 2 at 12:03 PM
$AIM some people are verry lucky to have a donkey, imagine how life would be without brains? 🫏 🫏🫏🫏🫏 🫏🫏🫏🫏 🫏🫏🫏🫏 🫏🫏🫏
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 9:05 PM
$AIM AMPLIGEN can change the world!
1 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 8:01 PM
$AIM aim management did a real shitty job for me. They turned 4 million in to 4K It is not because we dislike management that AMPLIGEN is worthless as the criminals who rob and robbed us state!
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 6:03 PM
$AIM the criminal naked shorting jokes
0 · Reply
uuddlrlr
uuddlrlr Jul. 1 at 5:41 PM
$AIM Voted NO on all measures. No reason to support the leadership team's initiatives when they have failed to demonstrate any level of competence towards shareholders. Good luck
1 · Reply
Latest News on AIM
AIM ImmunoTech Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 9 days ago

AIM ImmunoTech Proxy statement: Proxy filing


AIM ImmunoTech Registration statement: Registration filing

Jun 18, 2026, 8:00 AM EDT - 16 days ago

AIM ImmunoTech Registration statement: Registration filing


AIM ImmunoTech Proxy statement: Proxy filing

Jun 15, 2026, 8:00 AM EDT - 19 days ago

AIM ImmunoTech Proxy statement: Proxy filing


AIM ImmunoTech Inc trading resumes

2026-06-09T13:50:10.000Z - 25 days ago

AIM ImmunoTech Inc trading resumes


AIM ImmunoTech announces $2.65M registered direct offering

2026-06-09T13:41:34.000Z - 25 days ago

AIM ImmunoTech announces $2.65M registered direct offering


AIM ImmunoTech Inc trading halted, news pending

2026-06-09T13:29:35.000Z - 25 days ago

AIM ImmunoTech Inc trading halted, news pending


AIM ImmunoTech Registration statement: Registration filing

Jun 8, 2026, 8:00 AM EDT - 26 days ago

AIM ImmunoTech Registration statement: Registration filing


3 Penny Stocks Drawing Market Attention, 6/2/26

2026-06-02T17:36:51.000Z - 4 weeks ago

3 Penny Stocks Drawing Market Attention, 6/2/26

ANY HKIT


AIM ImmunoTech Inc trading resumes

2026-05-20T19:20:11.000Z - 6 weeks ago

AIM ImmunoTech Inc trading resumes


AIM ImmunoTech announces $2.4M registered direct offering

2026-05-20T19:10:27.000Z - 6 weeks ago

AIM ImmunoTech announces $2.4M registered direct offering


AIM ImmunoTech Inc trading halted, news pending

2026-05-20T19:00:12.000Z - 6 weeks ago

AIM ImmunoTech Inc trading halted, news pending


AIM ImmunoTech Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 7 weeks ago

AIM ImmunoTech Quarterly report: Q1 2026


AIM ImmunoTech Transcript: Virtual Investor Closing Bell

Apr 16, 2026, 4:00 PM EDT - 2 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell


AIM ImmunoTech Provides Routine Update on Annual Filings

Apr 13, 2026, 6:00 PM EDT - 2 months ago

AIM ImmunoTech Provides Routine Update on Annual Filings


AIM ImmunoTech Annual report: Q4 2025

Mar 27, 2026, 4:00 PM EDT - 3 months ago

AIM ImmunoTech Annual report: Q4 2025


Biotech Alert: Searches spiking for these stocks today

2026-03-20T14:55:28.000Z - 3 months ago

Biotech Alert: Searches spiking for these stocks today


Why Is AIM ImmunoTech Stock (AIM) Up Today?

2026-03-18T13:47:09.000Z - 3 months ago

Why Is AIM ImmunoTech Stock (AIM) Up Today?


AIM announces approval of patent for Ampligen in Japan

2026-03-18T12:51:46.000Z - 3 months ago

AIM announces approval of patent for Ampligen in Japan


AIM ImmunoTech Announces Closing of its Rights Offering

Mar 6, 2026, 7:00 PM EST - 4 months ago

AIM ImmunoTech Announces Closing of its Rights Offering


Biotech Alert: Searches spiking for these stocks today

2026-03-04T15:25:35.000Z - 4 months ago

Biotech Alert: Searches spiking for these stocks today


AIM ImmunoTech announces preliminary results of rights offering

2026-03-04T14:05:33.000Z - 4 months ago

AIM ImmunoTech announces preliminary results of rights offering


AIM ImmunoTech extends subscription period of rights offering

2026-02-25T14:19:06.000Z - 4 months ago

AIM ImmunoTech extends subscription period of rights offering


AIM ImmunoTech Transcript: Virtual Investor Closing Bell

Feb 19, 2026, 4:00 PM EST - 4 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell


AIM ImmunoTech Transcript: Corporate Connect Webinar Series

Feb 11, 2026, 1:40 PM EST - 5 months ago

AIM ImmunoTech Transcript: Corporate Connect Webinar Series


AIM ImmunoTech Announces Commencement of Rights Offering

Feb 11, 2026, 8:30 AM EST - 5 months ago

AIM ImmunoTech Announces Commencement of Rights Offering


AIM ImmunoTech Registration statement: Registration Filing

Feb 10, 2026, 7:00 AM EST - 5 months ago

AIM ImmunoTech Registration statement: Registration Filing


AIM ImmunoTech Registration statement: Registration Filing

Jan 29, 2026, 7:00 AM EST - 5 months ago

AIM ImmunoTech Registration statement: Registration Filing


AIM ImmunoTech Registration statement: Registration filing

Jan 23, 2026, 7:00 AM EST - 5 months ago

AIM ImmunoTech Registration statement: Registration filing


AIM ImmunoTech Transcript: AGM 2025

Dec 16, 2025, 11:00 AM EST - 7 months ago

AIM ImmunoTech Transcript: AGM 2025


AIM ImmunoTech Transcript: Virtual Investor Closing Bell Series

Dec 4, 2025, 4:00 PM EST - 7 months ago

AIM ImmunoTech Transcript: Virtual Investor Closing Bell Series


AIM ImmunoTech Quarterly report: Q3 2025

Nov 17, 2025, 4:00 PM EST - 8 months ago

AIM ImmunoTech Quarterly report: Q3 2025


AIM ImmunoTech Proxy statement: Proxy Filing

Oct 29, 2025, 8:30 AM EDT - 8 months ago

AIM ImmunoTech Proxy statement: Proxy Filing


AIM ImmunoTech to Attend the 2025 Maxim Growth Summit

Oct 20, 2025, 9:15 AM EDT - 9 months ago

AIM ImmunoTech to Attend the 2025 Maxim Growth Summit


AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Aug 21, 2025, 9:00 AM EDT - 11 months ago

AIM ImmunoTech Announces Release of the Next CEO Corner Segment


AIM ImmunoTech Quarterly report: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 11 months ago

AIM ImmunoTech Quarterly report: Q2 2025


AIM ImmunoTech Earnings release: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 11 months ago

AIM ImmunoTech Earnings release: Q2 2025


AIM ImmunoTech Resumes Trading on NYSE American

Jun 17, 2025, 8:55 AM EDT - 1 year ago

AIM ImmunoTech Resumes Trading on NYSE American


AIM ImmunoTech Announces 1-for-100 Reverse Stock Split

Jun 11, 2025, 4:15 PM EDT - 1 year ago

AIM ImmunoTech Announces 1-for-100 Reverse Stock Split


AIM ImmunoTech Quarterly report: Q1 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

AIM ImmunoTech Quarterly report: Q1 2025


AIM ImmunoTech Slides: Investor Presentation

Apr 8, 2025, 2:00 AM EDT - 1 year ago

AIM ImmunoTech Slides: Investor Presentation


Chessdoc
Chessdoc Jul. 3 at 9:00 PM
$AIM https://www.statnews.com/2026/06/30/marburg-virus-cases-ugandan-ebola-outbreak-zone/ Since Marburg is closely related to Ebola, Ampligen might have similar potential, but there are no published studies testing it directly against Marburg
0 · Reply
ultimatebastos
ultimatebastos Jul. 2 at 3:11 PM
$AIM what is wrong why are the moronic naked shorting thieves shorting so ineffective? And why do the still bash on this bord every day after they made the yahoo thief support board useless?
1 · Reply
Jasonbush
Jasonbush Jul. 2 at 3:03 PM
$AIM great drug terrible CEO
0 · Reply
jonjonson1234
jonjonson1234 Jul. 2 at 2:08 PM
$AIM For AIM insiders, the company has been a nice source of extra retirement income. All they have do is put in a few hours here and there going through the motions of running a hokey pantomime of a biotech, and then they can go back to riding horses, self-publishing books, playing golf, taking naps, etc. (For William Mitchell, at 91, it is probably mostly naps at this point). Thomas K. Equels, M.S., J.D. 73 Chief Executive Officer, President and Director Nancy Bryan, MBA 68 Director William M. Mitchell, M.D., Ph.D. 91 Chair of the Board and Director Ted D. Kellner 79 Director David Chemerow, MBA 74 Director Peter W. Rodino III, Esq. 74 Chief Operating Officer, General Counsel and Secretary Robert Dickey IV, MBA 70 Chief Financial Officer
1 · Reply
whatnow_32
whatnow_32 Jul. 2 at 1:42 PM
$AIM I voted NO for every option. This company would be better on the pink sheets. AND wtf is Tom doing every day to get Ampligen as a treatment for ebola? AND wtf are Kellner and Chemerow doing now that they have their board seats?
1 · Reply
ultimatebastos
ultimatebastos Jul. 2 at 12:03 PM
$AIM some people are verry lucky to have a donkey, imagine how life would be without brains? 🫏 🫏🫏🫏🫏 🫏🫏🫏🫏 🫏🫏🫏🫏 🫏🫏🫏
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 9:05 PM
$AIM AMPLIGEN can change the world!
1 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 8:01 PM
$AIM aim management did a real shitty job for me. They turned 4 million in to 4K It is not because we dislike management that AMPLIGEN is worthless as the criminals who rob and robbed us state!
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 6:03 PM
$AIM the criminal naked shorting jokes
0 · Reply
uuddlrlr
uuddlrlr Jul. 1 at 5:41 PM
$AIM Voted NO on all measures. No reason to support the leadership team's initiatives when they have failed to demonstrate any level of competence towards shareholders. Good luck
1 · Reply
jonjonson1234
jonjonson1234 Jul. 1 at 5:31 PM
$AIM I am sometimes puzzled by why ultimatebastos thinks that HEB/AIM is good investment. He has been promoting this stock since before the first FDA rejection of Ampligen in 2009, exhorting everyone to buy. At the time, the stock was trading at about $2.50 per share. With all of the reverse splits, the share price would need to reach $132,000.00 per share for him to break even on those 2009 shares. I remain mystified as to why he is so devoted to this stock after all these years.
1 · Reply
Pricewar
Pricewar Jul. 1 at 5:18 PM
$AIM This is same old playbook from Tom for years. Put out PR's, Webinars to lure in new investors, wont answer any questions, because he knows he is a crook. He Should of sold company years ago would of been happy with $25 but Tom f-cked everyone with a 100-1 RS now 25-1 RS everyone shares with be worthless Tom is a greedy MFer does not care about long shareholders that paid for his horse farm, horses, book deal and salary for years. You know company is going nowhere for years till P3 are complete and because Tom and Board are a bunch of crooks. If they had faith in their own company, they would be buying huge blocks of shares $400K at a time. But it is a Big Red Flag they don't because why would they lose their own money, when they can lose shareholders money instead. Just my opinion.... pissed off shareholder!
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 3:29 PM
$AIM where are all the disgusting naked shorts?
0 · Reply
ultimatebastos
ultimatebastos Jul. 1 at 11:10 AM
$AIM a few more illegal naked short attacks and I’ll have my extra shares.
1 · Reply
Aklim72
Aklim72 Jul. 1 at 8:16 AM
$DXF next $AIM . keep an eye on it
1 · Reply
bob397
bob397 Jun. 30 at 11:47 PM
$AIM ImmunoTech Accelerates Toward Potential Pivotal https://www.globenewswire.com/news-release/2026/06/24/3316820/29489/en/aim-immunotech-accelerates-toward-potential-pivotal-pancreatic-cancer-program-as-ampligen-continues-to-advance-through-key-clinical-milestones.html
1 · Reply
ultimatebastos
ultimatebastos Jun. 30 at 7:13 PM
$AIM https://www.yahoo.com/news/world/articles/patient-tested-suspected-ebola-virus-185224429.html
1 · Reply
ultimatebastos
ultimatebastos Jun. 30 at 6:51 PM
$AIM according to the naked shorts new investors just get in to get robbed by them asap. 🤣 What a joke…
0 · Reply
Paristommy
Paristommy Jun. 30 at 6:23 PM
$AIM Also voting No , doesn’t mean anything!! I have voted No the last 3-4 times , means absolutely nothing!!!
0 · Reply
Paristommy
Paristommy Jun. 30 at 6:21 PM
$AIM Wall Street not easy had enough shares to vote Scum Equels out , but instead sold us all out & believed Scum Equels bullshit !! He has me blocked, by the way !!What a total Scam from jump , I thought Pigs get full , but evidently not Equels !! Kellner another Thief , we all got played !!
1 · Reply
PhantaJuicy
PhantaJuicy Jun. 30 at 5:32 PM
$AIM VOTED NO on everything. Force incompetant greedy lazy leadership to take a more responsible path.
1 · Reply
ultimatebastos
ultimatebastos Jun. 30 at 3:57 PM
$AIM the madness is created by the ones barking hardest here.
0 · Reply